Medical devices, healthcare technology and the business of care
510(k) clearance · K251840

Zimmer Persona Personalized Knee System

Zimmer, Inc. · Decision date May 28, 2026

FDA DECISIONK251840

What did the FDA decide?

FDA records K251840 as a 510(k) premarket notification, with a decision dated May 28, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
May 28, 2026

FDA source record

Regulatory record facts

Identifier
K251840
Regulatory pathway
510(k) premarket notification
Applicant
Zimmer, Inc.
Product code
MBH
Decision code
SESE
Decision date
May 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer.

Applicant
Zimmer, Inc.
Product code
MBH
FDA device class
2

FDA decision timeline

  1. K251840 received

    Application receipt date recorded by FDA.

  2. K251840 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MBH

Product / regulatory recordCompanyPathwayDecision dateSource
Corin, Ltd.510(k) clearanceSep 17, 2026FDA
Smith & Nephew, Inc.510(k) clearanceSep 8, 2026FDA
Microport Orthopedics, Inc.510(k) clearanceAug 21, 2026FDA
Zimmer, Inc.510(k) clearanceMar 9, 2026FDA
Medacta International S.A.510(k) clearanceFeb 26, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zimmer, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Warsaw, IN

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records